Shares of The Estee Lauder Companies Inc. (NYSE: EL) were down over 3% on Tuesday. The stock has dropped 32% over the past three months. The company delivered better-than-expected earnings results for the fourth quarter of 2024, but it foresees challenges in the upcoming fiscal year and expects its performance to be more muted relative to the overall industry.
Q4 performance
Estee Lauder’s net sales increased 7% year-over-year to $3.87 billion in the fourth quarter of 2024. Organic sales increased 8%, helped by growth across all product categories. Adjusted EPS was $0.64 compared to $0.07 in the year-ago quarter.
During the quarter, Estee Lauder witnessed weakness in the mainland China and North America markets due to softness in overall prestige beauty, which may have been fueled by inflationary pressures in North America and a cautious consumer sentiment in China.
Organic sales increased 32% in the Europe, Middle East & Africa (EMEA) region, driven by growth in the Asia travel retail business and the developed European and priority emerging markets. Organic sales in Asia Pacific fell 4%, mainly due to the softness in overall prestige beauty in mainland China. Organic sales in the Americas dropped 5% due to the decline in North America, caused by heavy competition and the slowdown in prestige beauty.
FY2025 outlook
Estee Lauder expects global prestige beauty to grow 2-3% in fiscal year 2025, reflecting strength in many developed and emerging markets globally. Markets like North America are expected to see tempered growth while weak consumer sentiment is likely to cause continued declines in mainland China and Asia travel retail.
The company expects its performance in FY2025 to be more muted than the industry, primarily due to its significant business in mainland China and Asia travel retail. The challenges in mainland China and Asia travel retail are expected to pressure its results in the first quarter of 2025, as it continues to see weak consumer sentiment and more experiential spending.
For the first quarter of 2025, Estee Lauder expects net sales to decrease 3-5% year-over-year on both a reported and organic basis. Adjusted EPS is expected to range between $0.01-0.09 on a constant currency basis.
For FY2025, reported and organic net sales are forecasted to range between down 1% to up 2% versus the prior year. Adjusted EPS is expected to be $2.78-2.98 on a constant currency basis.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on